Your browser doesn't support javascript.
loading
The Clinically Approved Antifungal Drug Posaconazole Inhibits Human Cytomegalovirus Replication.
Mercorelli, Beatrice; Luganini, Anna; Celegato, Marta; Palù, Giorgio; Gribaudo, Giorgio; Lepesheva, Galina I; Loregian, Arianna.
Afiliação
  • Mercorelli B; Department of Molecular Medicine, University of Padua, Padua, Italy beatrice.mercorelli@unipd.it arianna.loregian@unipd.it.
  • Luganini A; Department of Life Sciences and Systems Biology, University of Turin, Turin, Italy.
  • Celegato M; Department of Molecular Medicine, University of Padua, Padua, Italy.
  • Palù G; Department of Molecular Medicine, University of Padua, Padua, Italy.
  • Gribaudo G; Department of Life Sciences and Systems Biology, University of Turin, Turin, Italy.
  • Lepesheva GI; Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Loregian A; Department of Molecular Medicine, University of Padua, Padua, Italy beatrice.mercorelli@unipd.it arianna.loregian@unipd.it.
Antimicrob Agents Chemother ; 64(10)2020 09 21.
Article em En | MEDLINE | ID: mdl-32690644
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Infecções por Citomegalovirus Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Preparações Farmacêuticas / Infecções por Citomegalovirus Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2020 Tipo de documento: Article